Clinical Trial: Safety and Efficacy of Botulinum Toxin-A Injection Into Ischiocavernosus Muscle for Premature Ejaculation

U.S., March 1 -- ClinicalTrials.gov registry received information related to the study (NCT06851598) titled 'Safety and Efficacy of Botulinum Toxin-A Injection Into Ischiocavernosus Muscle for Premature Ejaculation' on Feb. 24.

Brief Summary: The aim of this work is to assess the efficacy and safety of Botulinum toxin - A injection into ischiocavernosus muscle in treatment of primary premature ejaculation.

Study Start Date: July 01, 2024

Study Type: INTERVENTIONAL

Condition: Premature Ejaculation

Intervention: DRUG: 25 units botox

25 units of botox injection into ischiocavernosus muscle

DRUG: 50 units Botox

50 Units botox injection into ischiocavernosus muscle

DRUG: 75 units Botox

75 units botox injection into ischiocavernosus m...